Aclimostat is under investigation in clinical trial NCT03254368 (Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.